Dog Allergy Immunotherapy: Long-Term Relief for Atopic Dogs

Allergen-specific immunotherapy (ASIT) offers the only disease-modifying treatment for canine atopic dermatitis. Understanding how it works helps owners make informed welfare decisions.

Key Facts

Allergen-specific immunotherapy (ASIT) involves gradually desensitizing a dog to the allergens causing their atopic dermatitis.
It is the only treatment that addresses the underlying immune dysfunction rather than just managing symptoms.
ASIT is available as subcutaneous injections or sublingual drops — both are effective.
The treatment protocol involves an induction phase (increasing allergen doses over weeks to months) followed by a maintenance phase.
Approximately 50-70% of dogs show significant improvement with ASIT; full response may take 6-12 months to assess.
ASIT is most effective when started early in the disease course and when specific allergens are accurately identified.
Dogs on successful ASIT may require less or no ongoing medication, improving long-term welfare and reducing medication side effects.

Welfare Considerations

Allergen immunotherapy addresses a critical welfare need for dogs with atopic dermatitis — the chronic itch, skin damage, and recurrent infections of poorly controlled atopy cause significant suffering. Unlike symptomatic treatments that must be given indefinitely, ASIT aims to modify the underlying immune response, potentially allowing dogs to live more comfortably with reduced medication burden. The time required for response (6-12 months) requires patient commitment from owners. Dogs that respond well to ASIT experience dramatic improvements in comfort, skin condition, and quality of life. For those that do not respond, combination with other treatments is still beneficial. The long-term welfare and cost benefits of successful immunotherapy make it an important option for dogs with moderate to severe atopy.

What You Can Do

Discuss ASIT with a veterinary dermatologist if your dog has moderate to severe atopic dermatitis.
Ensure allergen testing (intradermal or serology) is performed to identify specific triggers before starting ASIT.
Commit to the full induction and at least one year of maintenance before evaluating response.
Combine ASIT with appropriate flea control and dietary management for maximum benefit.
Monitor and document your dog's itch severity and skin condition throughout treatment to track progress.
Ask your vet about sublingual immunotherapy as a needle-free alternative to injections if compliance is a concern.